Search Results - "Notarfranchi, Laura"

Refine Results
  1. 1
  2. 2

    Mechanisms of Action of the New Antibodies in Use in Multiple Myeloma by Romano, Alessandra, Storti, Paola, Marchica, Valentina, Scandura, Grazia, Notarfranchi, Laura, Craviotto, Luisa, Di Raimondo, Francesco, Giuliani, Nicola

    Published in Frontiers in oncology (08-07-2021)
    “…Monoclonal antibodies (mAbs) directed against antigen-specific of multiple myeloma (MM) cells have Fc-dependent immune effector mechanisms, such as…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Phase II Trial of Maintenance Treatment With IL2 and Zoledronate in Multiple Myeloma After Bone Marrow Transplantation: Biological and Clinical Results by Fazzi, Rita, Petrini, Iacopo, Giuliani, Nicola, Morganti, Riccardo, Carulli, Giovanni, Dalla Palma, Benedetta, Notarfranchi, Laura, Galimberti, Sara, Buda, Gabriele

    Published in Frontiers in immunology (03-02-2021)
    “…Maintenance treatment after autologous bone marrow transplantation in multiple myeloma improves the outcome of patients. We designed a phase II clinical trial…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Short-Term Risk of Progression of Patients with Asymptomatic Monoclonal Gammopathies to Active Multiple Myeloma: The Critical Impact of the Tumoral Mass by Dalla Palma, Anna Benedetta, Notarfranchi, Laura, Crosara, Jessica, Pedrazzoni, Mario, Accardi, Fabrizio, Marchica, Valentina, Toscani, Denise, Vicario, Emanuela, Storti, Paola, Giuliani, Nicola

    Published in Blood (13-11-2019)
    “…The identification of risk factors for progression is critical in the clinical management and appropriate follow up of patients with pre-malignant Asymptomatic…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20